MedPath

福建省福抗药业股份有限公司

Ownership
-
Established
2002-07-10
Employees
-
Market Cap
-
Website
http://www.fz-antibiotic.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

66

NMPA:66

Drug Approvals

Cefpirome Sulfate

Product Name
硫酸头孢匹罗
Approval Number
国药准字H20060331
Approval Date
Oct 15, 2024
NMPA

Kanamycin Monosulfate

Product Name
单硫酸卡那霉素
Approval Number
国药准字H35020443
Approval Date
Oct 15, 2024
NMPA

Cefotaxime Sodium

Product Name
头孢噻肟钠
Approval Number
国药准字H35020446
Approval Date
Oct 15, 2024
NMPA

Chlortetracycline Hydrochloride

Product Name
盐酸金霉素
Approval Number
国药准字H35020440
Approval Date
Sep 23, 2024
NMPA

Cefoperazone sodium

Product Name
头孢哌酮钠
Approval Number
国药准字H20054147
Approval Date
Sep 14, 2024
NMPA

Ceftriaxone Sodium

Product Name
头孢曲松钠
Approval Number
国药准字H20044903
Approval Date
Sep 14, 2024
NMPA

Ceftazidime

Product Name
头孢他啶
Approval Number
国药准字H20057294
Approval Date
Sep 14, 2024
NMPA

Sisomicin Sulfate

Product Name
硫酸西索米星
Approval Number
国药准字H20053239
Approval Date
Sep 5, 2024
NMPA

Tobramycin

Product Name
妥布霉素
Approval Number
国药准字H35020442
Approval Date
Sep 5, 2024
NMPA

Cefazolin Sodium

Product Name
头孢唑林钠
Approval Number
国药准字H35020439
Approval Date
Sep 5, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy